Nanobiotix

  • Placement of 1,596,527 new shares, representing 10% of Nanobiotix’ pre-deal outstanding share capital
  • Issue price of €15.75 per share represented a limited 1.4% discount versus the year-to-date average closing price
  • Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner in this transaction